Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Tuesday, April 30, 2013 Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Read More:
Research Suggests a New Approach for Overcoming Resistance to a Targeted Therapy for Prostate Cancer

Scroll to Top